Changes to CredibleMeds Lists - Pimavanserin, Nusinersen and Indacaterol
April 27, 2017 at 1:40 AM
The following changes have been made to the CredibleMed's lists of drugs:
1. Addition of Pimavanserin (antipsychotic for patients with Parkinson's disease) and Nusinersen (antisense drug for spinal muscular atrophy) to the Possible Risk (PR) List.
2. Addition of Indacaterol (a bronchodilator for asthma) to the Special Risk list (Drugs to Avoid in CLQTS)
We encourage everyone to use the new CredibleMeds smartphone app to gain immediate mobile access to the most up to date lists of drugs that prolong QT and/or have a risk of causing torsades de pointes arrhythmia.
Dr. Ray Woosley, AZCERT